Khautisen v. BHG Holdings LLC

CourtDistrict Court, D. South Carolina
DecidedAugust 23, 2024
Docket7:21-cv-03775
StatusUnknown

This text of Khautisen v. BHG Holdings LLC (Khautisen v. BHG Holdings LLC) is published on Counsel Stack Legal Research, covering District Court, D. South Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Khautisen v. BHG Holdings LLC, (D.S.C. 2024).

Opinion

IN THE DISTRICT COURT OF THE UNITED STATES FOR THE DISTRICT OF SOUTH CAROLINA SPARTANBURG DIVISION

Vanida Khautisen as Personal ) Case No. 7:21-cv-03775-JDA Representative of the Estate of ) Khouanexay Bill Sivilay, ) ) OPINION AND ORDER Plaintiff, ) ) v. ) ) BHG Holdings LLC, BHG XXXVIII ) LLC, ) ) Defendants. ) ) –––––––––––––––––––––––––––––– This matter is before the Court on Defendants’ motion for summary judgment and motions in limine. [Docs. 74; 93; 94; 116.] On November 18, 2021, Plaintiff filed this wrongful death and survival action asserting claims related to the death of Khouanexay Bill Sivilay (“Decedent”). [Doc. 1.] On July 20, 2023, Defendants filed a motion for summary judgment. [Doc. 74.] Plaintiff filed a response in opposition to the summary judgment motion on August 3, 2023 [Doc. 81], and Defendants filed a reply on August 8, 2023 [Doc. 83]. Defendants filed motions in limine on August 29, 2023, and January 2, 2024. [Docs. 93; 94; 116.] Plaintiff has filed responses in opposition to those motions [Docs. 103; 104; 117], and Defendants have filed replies [Docs. 105; 106; 118].1 Accordingly, all motions are ripe for review.2

1 Plaintiff also filed a notice of supplemental authority regarding one of Defendants’ motions in limine, to which Defendants filed a reply. [Docs. 127; 128.]

2 This case was reassigned to the undersigned on February 13, 2024. [Doc. 121.] BACKGROUND In ruling on a motion for summary judgment, this Court reviews the facts and reasonable inferences in the light most favorable to the nonmoving party. Scott v. Harris, 550 U.S. 372, 378 (2007); see also Hardwick ex rel. Hardwick v. Heyward, 711 F.3d 426, 433 (4th Cir. 2013). Viewed in the light most favorable to Plaintiff, the summary judgment

record reveals the following facts.3 Defendants operate methadone clinics4 in the United States, one of which is BHG Spartanburg Treatment Center located in Spartanburg, South Carolina (“BHG”).5 [Docs. 1 ¶¶ 2–3; 15 ¶¶ 5–6.] On June 2, 2020, a patient named Trent Neal (“Neal”)6 began treatment at BHG, indicating that he wanted to get off heroin7 and that he had also abused

3 As will be explained, Defendants’ motion for summary judgment argues only that they did not owe Decedent a duty of care. [Docs. 74; 74-1.] Accordingly, the Court limits its discussion of the facts of the case to those necessary to give a general background and to resolve the motion for summary judgment.

4 Methadone is a long-acting full opioid agonist mediation and is used to treat Opioid Use Disorder. Methadone, Substance Abuse and Mental Health Services Administration, https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling- related-conditions/methadone (last visited Aug. 9, 2024). Methadone “reduces opioid craving and withdrawal and blunts or blocks the effects of opioids.” Id.

5 According to Defendants, Defendant BHG Holdings, LLC is the parent company of Defendant BHG XXXVIII, LLC d/b/a BHG Spartanburg. [Doc. 74-1 at 1 n.1.]

6 Defendants refer to Neal as “T.N.” in their filings. [See Doc. 74-1.] However, Neal has executed a declaration waiving his rights to privacy and/or confidentiality regarding his relationship with BHG and its medical providers. [Doc. 75-1.] Thus, the Court refers to him by name.

7 “Heroin is an opioid drug made from morphine, a natural substance taken from the seed pod of the various opium poppy plants grown in Southeast and Southwest Asia, Mexico, and Colombia.” Heroin, National Institute on Drug Abuse, https://nida.nih.gov/research- topics/heroin (last visited Aug. 9, 2024). THC8 and morphine. [Doc. 81-13 at 2–3.] During intake, Neal received and signed multiple patient education forms, including information about methadone and a benzodiazepine9 education form warning that “[c]ombining benzodiazepines with medication assisted treatment can have serious health risks.” [Doc. 74-3.] Neal received his first methadone dose of 30 milligrams on June 3, 2020. [Docs.

81-2 at 2; 81-13 at 2.] As part of his treatment plan, Neal was required to attend clinic daily, ask for needed dose increases, take urine drug screenings, and meet regularly with a counselor. [Doc. 81-13 at 2.] He continued with methadone doses at BHG through December 25, 2020, increasing his doses periodically by 5 milligrams until he reached a dose of 60 milligrams. [Doc. 81-2 at 1–18.] During the time Neal was treated at BHG, he was subjected to approximately 31 drug screenings. [Id. at 19–29.] Of those 31 drug screenings, he tested positive for morphine two times, THC seven times, opiates 27 times, amphetamines10 15 times, and benzodiazepines 8 times. [Id.] The summary judgment record includes counseling notes from two sessions with

Neal: an in-person session that lasted a little over one hour on October 23, 2020, and a

8 “Tetrahydrocannabinol (THC) is one of the main active components found in marijuana. It acts as a mild sedative at low doses and a hallucinogen at high doses.” Tetrahydrocannabinol, ScienceDirect, https://www.sciencedirect.com/topics/neuro science/tetrahydrocannabinol (last visited Aug. 9, 2024).

9 “Benzodiazepines are depressants that produce sedation and hypnosis, relieve anxiety and muscle spasms, and reduce seizures.” Benzodiazepines, United States Drug Enforcement Administration, https://www.dea.gov/factsheets/benzodiazepines (last visited Aug. 9, 2024). Benzodiazepine “[a]buse is particularly high among heroin and cocaine users,” and “opioid users often co-abuse benzodiazepines to enhance euphoria.” Id.

10 “Amphetamines are stimulants that speed up the body’s system.” Amphetamines, United States Drug Enforcement Administration, https://www.dea.gov/factsheets/ amphetamines (last visited Aug. 9, 2024). telehealth session that lasted 15 minutes on November 19, 2020. [Doc. 74-5.] In the October session, Neal and the counselor discussed his positive drug screenings and the possibility of requesting an increase in his methadone dose to minimize Neal’s urge for self-medicating. [Id. at 1.] In the November session, they discussed his positive drug screenings for benzodiazepines, amphetamines, opiates, and THC, and the counselor

explained “the harmful effects that those substances could have on [his] health.” [Id. at 3.] On December 24, 2020, Neal reported to BHG for his regular daily methadone dose and additionally received one take-home methadone dose for Christmas day when BHG would be closed. [Docs. 1 ¶ 26; 15 ¶ 18; 81-2 at 17.] On December 26, 2020, Neal missed his daily methadone dose because he arrived at the clinic after it had closed for dosing. [Docs. 81-2 at 17; 81-18 at 3–5 (7:16–9:4).11] Around 9:22 a.m. on December 26, after he left the clinic, Neal was driving on Highway 176 in Spartanburg when he ran a red light and struck Decedent’s vehicle,

causing Decedent’s death. [Doc. 81-19.] A post-collision toxicology report concerning Neal showed positive results for THC, methadone, and benzodiazepines. [Doc. 81-20.] Neal was arrested for felony driving under the influence with death, and the arresting officer found a small plastic bag with narcotic residue in it when he searched Neal. [Doc. 81-19 at 8.]

11 The deposition testimony reflects that this missed dose occurred on December 23, 2020. [Doc. 81-18 at 3 (7:16–17).] However, that date appears to be an error because Neal’s dosing history shows that he received a methadone dose on December 23, 2020 [Doc. 81-2 at 17], and all parties indicate that this missed dose occurred on December 26, 2020 [Docs. 74-1 at 7; 81 at 11–12].

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Diebold, Inc.
369 U.S. 654 (Supreme Court, 1962)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Scott v. Harris
550 U.S. 372 (Supreme Court, 2007)
Hardwick Ex Rel. Hardwick v. Heyward
711 F.3d 426 (Fourth Circuit, 2013)
Jackson v. Swordfish Investments, L.L.C.
620 S.E.2d 54 (Supreme Court of South Carolina, 2005)
Madison Ex Rel. Bryant v. Babcock Center
638 S.E.2d 650 (Supreme Court of South Carolina, 2006)
Bishop v. South Carolina Department of Mental Health
502 S.E.2d 78 (Supreme Court of South Carolina, 1998)
Rogers v. South Carolina Department of Parole & Community Corrections
464 S.E.2d 330 (Supreme Court of South Carolina, 1995)
Hardee v. Bio-Medical Applications of South Carolina, Inc.
636 S.E.2d 629 (Supreme Court of South Carolina, 2006)
Thomasko v. Poole
561 S.E.2d 597 (Supreme Court of South Carolina, 2002)
Singleton v. Sherer
659 S.E.2d 196 (Court of Appeals of South Carolina, 2008)
Melton v. Medtronic, Inc.
698 S.E.2d 886 (Court of Appeals of South Carolina, 2010)
Faile v. South Carolina Department of Juvenile Justice
566 S.E.2d 536 (Supreme Court of South Carolina, 2002)
Baughman v. General Motors Corp.
627 F. Supp. 871 (D. South Carolina, 1985)
Oblachinski v. Reynolds
706 S.E.2d 844 (Supreme Court of South Carolina, 2011)
Jeffery Moore v. Equitrans, L.P.
27 F.4th 211 (Fourth Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
Khautisen v. BHG Holdings LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/khautisen-v-bhg-holdings-llc-scd-2024.